Related LncRNAs | |||||||||
---|---|---|---|---|---|---|---|---|---|
ID | lncRNA Name | Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source |
EL0526 | GAS5 | kidney cancer | N/A | N/A | N/A | expression | Tumour suppressor | 24373479 | LncRNADisease |
EL0556 | H19 | kidney cancer | N/A | N/A | N/A | regulation | Tumour suppressor; tumour suppressor host | 24373479 | LncRNADisease |
EL0569 | HIF1A-AS1 | kidney cancer | N/A | N/A | N/A | expression | Diagnostic and discriminative marker | 24373479 | LncRNADisease |
EL0569 | HIF1A-AS1 | kidney cancer | qPCR etc. | renal cancer tissue | up-regulated | expression | The antitumor DNA topoisomerase I (Top1) inhibitor camptothecin (CPT) increases the cellular levels of two antisense lncRNAs at the 5' (5'aHIF-1 alpha) and 3' (3'aHIF-1 alpha) ends of the human HIF1A-AS1 gene. | 21897117 | LncRNADisease Lnc2Cancer |
EL0570 | HIF1A-AS2 | kidney cancer | N/A | N/A | N/A | expression | Diagnostic and discriminative marker | 24373479 | LncRNADisease |
EL0628 | KCNQ1OT1 | kidney cancer | N/A | N/A | N/A | regulation | Oncogene | 24373479 | LncRNADisease |
EL0853 | MALAT1 | kidney cancer | N/A | N/A | N/A | regulation | Oncogene | 24373479 | LncRNADisease |
EL0861 | MEG3 | kidney cancer | N/A | N/A | N/A | expression | Tumour suppressor | 24373479 | LncRNADisease |